Evaluation on Glycaemic Control and Weight Change of Once Daily Levemir (Insulin Detemir) in Type 2 Diabetes Mellitus Treated by an Intensive Insulin Treatment (ICT).
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LEONCET2
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 20 May 2009 Actual patient number (2289) added as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.